Valeant Pharmaceuticals International Inc (VRX)

17.60
0.35 2.03
NYSE : Health Care
Prev Close 17.25
Open 17.18
Day Low/High 17.18 / 17.74
52 Wk Low/High 8.31 / 32.74
Volume 10.83M
Avg Volume 23.76M
Exchange NYSE
Shares Outstanding 347.91M
Market Cap 6.00B
EPS -6.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Valeant Takes Haircut on 2013 Obagi Deal as Debt Pile Looms, Divestitures Continue

Valeant Takes Haircut on 2013 Obagi Deal as Debt Pile Looms, Divestitures Continue

Valeantacquired Obagi for $420 million but has sold the business for a fraction.

Stocks Cling to Flatline as Wall Street Awaits Earnings

Stocks Cling to Flatline as Wall Street Awaits Earnings

Stocks hold close to flat of a rush of earnings reports this week.

S&P 500, Nasdaq Rise as Wall Street Plays Earnings Wait-and-See, Apple Climbs

S&P 500, Nasdaq Rise as Wall Street Plays Earnings Wait-and-See, Apple Climbs

Stocks mostly higher ahead of a rush of earnings reports this week.

Stock Futures Creep Higher Ahead of Earnings Rush

Stock Futures Creep Higher Ahead of Earnings Rush

Stock futures higher ahead of a rush of earnings reports this week.

Valeant Suffers Another Blow After the Approval of Johnson & Johnson's Psoriasis Treatment

Valeant Suffers Another Blow After the Approval of Johnson & Johnson's Psoriasis Treatment

The approval of Johnson & Johnson's psoriasis treatment will have an adverse impact on Valeant in the second half of 2017, Wells Fargo argued.

Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher

Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher

The redemption follows the July 10 announcement that Valeant would pay down $811 million of its senior secured term loans.

Jim Cramer on Facebook, Snap, Nvidia, Intel, Boeing, Arconic, Southwest Air, Valeant, Pepsi and Amazon Prime Day

Jim Cramer on Facebook, Snap, Nvidia, Intel, Boeing, Arconic, Southwest Air, Valeant, Pepsi and Amazon Prime Day

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Monday's trending stocks.

Valeant Continues Quest to Repay Massive $30 Billion Debt Load, Shares Close Higher

Valeant Continues Quest to Repay Massive $30 Billion Debt Load, Shares Close Higher

Valeant used proceeds from the Dendreon divestiture to help with its drive to pay down a total of $5 billion in debt.

Closing Bell: Retail Hit as Amazon Kicks Off Prime Day; Tech Boosts Nasdaq Again

Closing Bell: Retail Hit as Amazon Kicks Off Prime Day; Tech Boosts Nasdaq Again

More gains in tech pushed the Nasdaq to clock its second day of solid gains.

Nasdaq Leads Wall Street Higher as Tech Shares Restart Rally

Nasdaq Leads Wall Street Higher as Tech Shares Restart Rally

Stocks rise, led higher by the Nasdaq as tech space finds momentum.

Stocks Rise as Tech Shares Find Renewed Momentum

Stocks Rise as Tech Shares Find Renewed Momentum

Stocks rise in quiet start to week.

Stock Futures Mixed as Week Starts Quietly Ahead of Yellen Testimony

Stock Futures Mixed as Week Starts Quietly Ahead of Yellen Testimony

Stock futures mixed in quiet start to week.

Activists Forced CEOs to Leave These Huge Companies This Year

Activists Forced CEOs to Leave These Huge Companies This Year

The top executives at these seven companies all left after pressure from activist investors in 2017.

Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps

Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps

The Laval, Quebec-based specialty pharmaceutical company is likely to sell off more of its business segments as it seeks to pay down nearly $29 billion in debt.

Paulson Ups Valeant Stake; Activist Investor Targets Nestle -- ICYMI Monday

Paulson Ups Valeant Stake; Activist Investor Targets Nestle -- ICYMI Monday

Here's what you need to know now.

Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers

Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers

Seattle Genetics, FibroGen and Sangamo were among the biotech stock movers in premarket trading on June 26.

These Stocks Are Changing Course

These Stocks Are Changing Course

Bullish and bearish reversals for this week.

Who's Afraid of the Amazon Empire?: Cramer's 'Mad Money' Recap (Thursday 6/22/17)

Who's Afraid of the Amazon Empire?: Cramer's 'Mad Money' Recap (Thursday 6/22/17)

Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.

Citigroup, Zoetis, AbbVie, Mattel, Valeant Pharmaceuticals 'Mad Money' Lightning Round

Citigroup, Zoetis, AbbVie, Mattel, Valeant Pharmaceuticals 'Mad Money' Lightning Round

Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.

Dow and S&P 500 Rip Higher to New Records -- Thanks Apple and Amazon!

Dow and S&P 500 Rip Higher to New Records -- Thanks Apple and Amazon!

A tech recovery pushes the S&P 500 and Dow to records.

Dow and S&P 500 on Track for Records as Apple Drives a Tech Recovery

Dow and S&P 500 on Track for Records as Apple Drives a Tech Recovery

Stocks move higher as tech sector names make gains.